Effects of intermittent IL-2 alone or with peri-cycle antiretroviral therapy in early HIV infection: the STALWART study. [electronic resource]
Producer: 20100930Description: e9334 p. digitalISSN:- 1932-6203
- Adult
- Anti-HIV Agents -- adverse effects
- Atazanavir Sulfate
- CD4 Lymphocyte Count
- Carbamates -- therapeutic use
- Drug Administration Schedule
- Drug Therapy, Combination
- Female
- Fever -- chemically induced
- Furans
- HIV Infections -- drug therapy
- Humans
- Interleukin-2 -- adverse effects
- Lopinavir
- Male
- Nausea -- chemically induced
- Oligopeptides -- therapeutic use
- Opportunistic Infections -- chemically induced
- Organophosphates -- therapeutic use
- Pyridines -- therapeutic use
- Pyrimidinones -- therapeutic use
- Ritonavir -- therapeutic use
- Sulfonamides -- therapeutic use
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.